present study was to explore the clinical feature of AFLP.
From January 1996 to January 2012, forty-two cases of AFLP were identified at Beijing Ditan Hospital. Six patients had positive test results for hepatitis B. All patients had an abdominal ultrasound examination, but bright liver were only seen in 25 cases. Four cases were confirmed by liver biopsy.
The average maternal age was 27.5 years (range, 21−34 years); The average gestational age at delivery was 35.6 weeks (range, 26−40 weeks). Symptoms occurring included jaundice or dark urine (n=28), nausea and vomiting (n=22), malaise (n=23), abdominal pain (n=10) and pruritus (n=6). Five patients had no prodrome and no complaints at the time of admission.
Laboratory results during hospital for the 42 patients are displayed in Table 1 . There were 3 maternal deaths (7.14%) respectively for cerebral hemorrhage, obstetric hemorrhage and multi-organ dysfunction syndrome. No liver transplantation was performed. Maternal morbidity included acute renal injury (n=36), acute renal failure (n=15), postpartum hemorrhage over than 500 ml (n=15), hypoglycemia (n=14), hepatic encephalopathy (n=14), disseminated intravascular coagulation (n=14). Serious obstetric complication included premature delivery (n=24), neonatal asphyxia (n=22), preeclampsia (n=5).
The cause of AFLP is still unknown, but it had been reported in association with fetal LCHAD deficiency.
2 The symptoms and laboratory findings in this series were similar to those found previously. There were six patients (22.2%) who were HBV carrier before onset, but the HBV-DNA and anti-HBV-IgM were negative at admission. Aminotransferase levels were found to be significantly higher in fulminant viral hepatitis; serum transaminase levels in AFLP rarely exceed 1000 U/L. Pre-eclampsia is frequently associated with AFLP, but is not common in fulminant viral hepatitis.
3
The overall morbidity of renal impairment (Cr>150 μmol/L) was 74.4% and incidence of ARF need renal replacement treatment was 34.9%. Laboratory evidence of acute hepatic failure combined with some degree of renal impairment may help to distinguish AFLP from other causes of perpartum jaundice. Morbidity of leukocytosis was significant high even in the early course. Non-invasive tools such as abdominal ultrasound and computed tomography have uncertain value in making a final diagnosis of AFLP. But it allows to dismiss some diagnosis of jaundice.
In conclusion, AFLP causes severe maternal morbidity and mortality, and perinatal mortality remains high. Some complications such as ARF, leukocytosis may contribute to the early diagnosis of AFLP.
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